Baker Brothers Advisors - GALMED PHARMACEUTICALS LTD ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2021$634,000
+10.3%
184,9270.0%0.00%
+50.0%
Q4 2020$575,000
-20.7%
184,927
-10.0%
0.00%
-33.3%
Q3 2020$725,000
-29.7%
205,375
-4.7%
0.00%
-40.0%
Q2 2020$1,031,000
+38.2%
215,5940.0%0.01%0.0%
Q1 2020$746,000
-40.1%
215,5940.0%0.01%
-28.6%
Q4 2019$1,246,000
+20.9%
215,5940.0%0.01%0.0%
Q3 2019$1,031,000
-35.0%
215,5940.0%0.01%
-36.4%
Q2 2019$1,585,000
-10.0%
215,5940.0%0.01%0.0%
Q1 2019$1,761,000
+19.6%
215,5940.0%0.01%
-8.3%
Q4 2018$1,473,000
-66.5%
215,594
-33.5%
0.01%
-58.6%
Q3 2018$4,401,000
-41.9%
324,094
-49.1%
0.03%
-49.1%
Q2 2018$7,570,000636,1400.06%
Other shareholders

There were no reported owners of GALMED PHARMACEUTICALS LTD in Q3 2023.

NameSharesValueWeighting ↓
View complete list of GALMED PHARMACEUTICALS LTD shareholders